Nektar Therapeutics (NKTR) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

NKTR rapporto: 74%

100%

NKTR supera 26 di 35 ultime stime

Data del prossimo reportMar 3, 2025

Stimato per Q4 24:$-0.22

Cambiamenti implicati per il Q3 24:+22.22%

Cambiamenti implicati per il Q4 23:0.00%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q3 24	Nov 7, 2024	$-0.18 / $-0.23	$0.05 / 21.74%
Q2 24	Aug 8, 2024	$-0.25 / $-0.21	$-0.04 / -19.05%
Q1 24	May 9, 2024	$-0.18 / $-0.21	$0.03 / 14.29%
Q4 23	Mar 4, 2024	$-0.22 / $-0.2	$-0.02 / -10%
Q3 23	Nov 7, 2023	$-0.19 / $-0.18	$-0.01 / -5.56%
Q2 23	Aug 8, 2023	$-0.27 / $-0.3	$0.03 / 10%
Q1 23	May 9, 2023	$-0.25 / $-0.26	$0.01 / 3.85%
Q4 22	Feb 28, 2023	$-0.32 / $-0.45	$0.13 / 28.89%

Fornitori di Dati: Xignite Logo